'Crush-Resistant' OxyContin Patents Fail At Fed. Circ.
By Andrew Karpan · January 2, 2025, 4:13 PM EST
In one of its last major moves in 2024, the Federal Circuit decided to reject an appeal from the bankrupt maker of OxyContin, which is trying to use patent laws to...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login